No, you are jumping to the wrong conclusion when you believe he suspected a portion of the patients caused the triggering. It was the futility of the entire patient population that caused the triggering. King (as any biopharm would do) went in to analyze the data and found a nugget of positive data. on the 10th, we will learn how big that nugget is, but we know it isn't across the entire patient population.